Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kailan Sierra-Davidson"'
Autor:
Benjamin H. Kann, Raymond H. Mak, Lisa Singer, Kailan Sierra-Davidson, David Kozono, Abby White, Kevin X. Liu, Kevin Tyan, Lawrence T. Orlina, J. Paul Marcoux
Publikováno v:
Radiother Oncol
BackgroundTrimodality therapy (TMT) with preoperative chemoradiation followed by surgical resection is used for locally-advanced non-small-cell lung cancer (LA-NSCLC). Traditionally, preoperative radiation doses ≤54Gy are used due to concerns regar
Autor:
Kailan Sierra-Davidson, David Kozono, Benjamin H. Kann, Raymond H. Mak, Kevin Tyan, Kevin X. Liu, Lisa Singer, Lawrence T. Orlina, Abby White, J.P. Marcoux
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e445-e446
PURPOSE/OBJECTIVE(S) Trimodality therapy (TMT) with preoperative chemoradiation followed by surgical resection is used in the management of locally-advanced non-small cell lung cancer (LA-NSCLC). Traditionally, preoperative radiation doses ≤54 Gy a
Publikováno v:
Journal of Surgical Case Reports
Desmoid tumors are rare malignancies derived from myofibroblasts, which can cause significant morbidity due to life-threatening invasion of local structures. Risk factors include familial adenomatous polyposis, antecedent surgical trauma and estrogen
Autor:
Andrew S, Ishizuka, Kirsten E, Lyke, Adam, DeZure, Andrea A, Berry, Thomas L, Richie, Floreliz H, Mendoza, Mary E, Enama, Ingelise J, Gordon, Lee-Jah, Chang, Uzma N, Sarwar, Kathryn L, Zephir, LaSonji A, Holman, Eric R, James, Peter F, Billingsley, Anusha, Gunasekera, Sumana, Chakravarty, Anita, Manoj, MingLin, Li, Adam J, Ruben, Tao, Li, Abraham G, Eappen, Richard E, Stafford, Natasha, K C, Tooba, Murshedkar, Hope, DeCederfelt, Sarah H, Plummer, Cynthia S, Hendel, Laura, Novik, Pamela J M, Costner, Jamie G, Saunders, Matthew B, Laurens, Christopher V, Plowe, Barbara, Flynn, William R, Whalen, J P, Todd, Jay, Noor, Srinivas, Rao, Kailan, Sierra-Davidson, Geoffrey M, Lynn, Judith E, Epstein, Margaret A, Kemp, Gary A, Fahle, Sebastian A, Mikolajczak, Matthew, Fishbaugher, Brandon K, Sack, Stefan H I, Kappe, Silas A, Davidson, Lindsey S, Garver, Niklas K, Björkström, Martha C, Nason, Barney S, Graham, Mario, Roederer, B Kim Lee, Sim, Stephen L, Hoffman, Julie E, Ledgerwood, Robert A, Seder
Publikováno v:
Nature medicine. 22(6)
Autor:
Sumana Chakravarty, Eric R. James, Tao Li, Kirsten E. Lyke, Abraham G. Eappen, Mario Roederer, Laura Novik, Adam Ruben, Uzma N. Sarwar, Anita Manoj, Sebastian A. Mikolajczak, Hope Decederfelt, Cynthia S. Hendel, Brandon K. Sack, Stefan H. I. Kappe, Pamela Costner, Matthew B. Laurens, Mary E. Enama, Adam DeZure, Niklas K. Björkström, Jay Noor, Lindsey S. Garver, Silas A. Davidson, Natasha K C, B. Kim Lee Sim, William R Whalen, Julie E. Ledgerwood, Stephen L. Hoffman, Barbara J. Flynn, Minglin Li, Andrew S. Ishizuka, Robert A. Seder, Martha Nason, Judith E. Epstein, Peter F. Billingsley, Lee-Jah Chang, Sarah H. Plummer, Ingelise J. Gordon, Christopher V. Plowe, Kailan Sierra-Davidson, Richard E. Stafford, Margaret A. Kemp, Barney S. Graham, Anusha Gunasekera, Kathryn L Zephir, Srinivas S. Rao, Thomas L. Richie, Tooba Murshedkar, LaSonji A. Holman, John Paul Todd, Floreliz Mendoza, Matthew Fishbaugher, Jamie G. Saunders, Andrea A. Berry, Gary A. Fahle, Geoffrey M. Lynn
Publikováno v:
Nature medicine. 22(6)
An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown. We assessed how vaccine
Autor:
Katie Ewer, Tommy Rampling, Navin Venkatraman, Georgina Bowyer, Danny Wright, Teresa Lambe, Egeruan B. Imoukhuede, Ruth Payne, Sarah Katharina Fehling, Thomas Strecker, Nadine Biedenkopf, Verena Krähling, Claire M. Tully, Nick J. Edwards., Emma M. Bentley, Dhanraj Samuel, Geneviève Labbé, Jing Jin, Malick Gibani., Alice Minhinnic, Morven Wilkie, Ian Poulton, Natalie Lella, Rachel Roberts, Felicity Hartnell, Carly Bliss, Kailan Sierra-Davidson, Jonathan Powlson, Eleanor Berrie, Richard Tedder, B. Chir., Francois Roman, Iris De Ryck, Alfredo Nicosia, Nancy J. Sullivan, Daphne A. Stanley, Olivier T. Mbaya, Julie E. Ledgerwood, Richard M. Schwartz, Loredana Siani, Stefano Colloca, Antonella Folgori, Stefania Di Marco, Riccardo Cortese, Edward Wright, Stephan Becker, Barney S. Graham, Richard A. Koup, Myron M. Levine, Ariane Volkmann, Paul Chaplin, Andrew J. Pollard, Simon J. Draper, D. Phil., W. Ripley Ballou, Alison Lawrie, Sarah C. Gilbert, and Adrian V. S. Hill
BACKGROUND\ud The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak.\ud \ud METHODS\ud In this phase 1 stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180dc9091c76e4ca78fdb439784cfb18
https://westminsterresearch.westminster.ac.uk/download/73fc5235cecfad936d01e4885891d2bdbd8509ccc9118034132a348b6eac7ac2/444979/nejmoa1411627.pdf
https://westminsterresearch.westminster.ac.uk/download/73fc5235cecfad936d01e4885891d2bdbd8509ccc9118034132a348b6eac7ac2/444979/nejmoa1411627.pdf
Progress with viral vectored malaria vaccines: A multi-stage approach involving 'unnatural immunity'
Autor:
Katie J, Ewer, Kailan, Sierra-Davidson, Ahmed M, Salman, Joseph J, Illingworth, Simon J, Draper, Sumi, Biswas, Adrian V S, Hill
Publikováno v:
Vaccine
Viral vectors used in heterologous prime-boost regimens are one of very few vaccination approaches that have yielded significant protection against controlled human malaria infections. Recently, protection induced by chimpanzee adenovirus priming and
Autor:
Damien Z. Soghoian, Srinika Ranasinghe, Hendrik Streeck, Jenna Rychert, Abraham L. Brass, Isaiah Davis, Sam Cutler, Alicja Piechocka-Trocha, Heiko Jessen, Kimberly Lane, Eric S. Rosenberg, Jason M. Brenchley, Kailan Sierra-Davidson, Madelene Lindqvist, Bruce D. Walker, Michael Flanders, Thomas Pertel
Publikováno v:
Science translational medicine. 4(123)
Early immunological events during acute HIV infection are thought to fundamentally influence long-term disease outcome. Whereas the contribution of HIV-specific CD8 T cell responses to early viral control is well established, the role of HIV-specific